THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES
LaoBiz.com profiles the Laos Patent “THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES” from open registry fields, filed by KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D on 2013-12-20; current status: Abandoned. Identifiers include application No. P/374; DIP id LAP374; protection kind Patent - PCT National Phase. Key dates: publication 2025-12-12. Classification: A61K 31/519、A61P 35/00、C07D 487/04. Inventor(s)/designer(s): Anant Ramrao GHAWALKAR, Bart VANDERHOYDONCK, Daneil James FORD, Helen Tracey HORSLEY, James Thomas REUBERSON. Abstract hint: A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4- position by a diaza monocyclic, bridged bicyclic or spiroc…. Unique application identifiers, holders and classification text are surfaced here to reduce near-duplicate IP landing pages; always verify against the competent office.
P/374
Mark
Key facts
- Type
- Patent
- App. no.
P/374- Status
- Abandoned
- Applicant
- KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D ； UCB BIOPHARMA SPRL
- Agent
- Lao Trademark Agency
- Filing date
- 2013-12-20
- Publication
- 2025-12-12
- Protection kind
- Patent - PCT National Phase
- Priority
- GB · 1223021.5 · 2012-12-20
- Applicant address
- KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D · 5105 Minderbroedersstraat 8a B-3000 Leuven · BE；UCB BIOPHARMA SPRL · 60 Allee de la Recherche, B-1070 Brussels, Belgium · BE
- Agent address
- Lao Trademark Agency · LLC Bldg, Nongbone Road, Ban Nongbone, Saysettha District, P.O. Box: 925, Vientiane, LAO P.D.R · LA
- Nice / IPC classes
- A61K 31/519 · A61P 35/00 · C07D 487/04
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination Refused / terminated
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4- position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders; viral diseasesand malaria; and organ and cell transplant rejection.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP374.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP374.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP374.html?lang=en · CC BY 4.0